Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
4.140
+0.270 (6.98%)
Sep 17, 2026, 4:00 PM EDT - Market closed
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $55.94 million as of September 17, 2026. Its market cap has increased by 223.10% in one year.
Market Cap
55.94M
Enterprise Value
45.61M
1-Year Change
223.10%
Ranking
Category
Stock Price
$4.14
ChartMarket Cap Chart
Since June 10, 2019, Edesa Biotech's market cap has increased from $37.12M to $55.94M, an increase of 50.70%. That is a compound annual growth rate of 5.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 55.94M | 372.69% |
| Dec 31, 2025 | 11.83M | 103.14% |
| Dec 31, 2024 | 5.83M | -59.72% |
| Dec 29, 2023 | 14.46M | -65.40% |
| Dec 30, 2022 | 41.80M | -45.08% |
| Dec 31, 2021 | 76.11M | 70.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Serina Therapeutics | 59.69M |
| Heron Therapeutics | 59.61M |
| Xilio Therapeutics | 59.22M |
| Dogwood Therapeutics | 58.81M |
| MiNK Therapeutics | 58.23M |
| Impact BioMedical | 57.04M |
| ImageneBio | 56.47M |
| MindWalk Holdings | 54.27M |